Cargando…
Topical Drug Delivery to the Posterior Segment of the Eye
Topical drug delivery to the posterior segment of the eye is a very complex challenge. However, topical delivery is highly desired, to achieve an easy-to-use treatment option for retinal diseases. In this review, we focus on the drug characteristics that are relevant to succeed in this challenge. An...
Autores principales: | Löscher, Marina, Seiz, Chiara, Hurst, José, Schnichels, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779621/ https://www.ncbi.nlm.nih.gov/pubmed/35057030 http://dx.doi.org/10.3390/pharmaceutics14010134 |
Ejemplares similares
-
Lipid-DNA Nanoparticles as Drug-Delivery Vehicles for the Treatment of Retinal Diseases
por: Schnichels, Sven, et al.
Publicado: (2023) -
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
por: Rodrigues, Gerard A., et al.
Publicado: (2018) -
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles
por: Tahara, Kohei, et al.
Publicado: (2017) -
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
por: Vaneev, Alexander, et al.
Publicado: (2021) -
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
por: Varela-Fernández, Rubén, et al.
Publicado: (2020)